Lumosity

News

A study of nearly 20,000 adults with self-reported ADHD diagnoses shows app-based games can improve scores on a battery of cognitive tests.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.